Understanding new treatment protocols for severe dry eye

  At the completion of this CPD activity, optometrists will have developed their knowledge of treatment options for severe dry eye disease. Including: Understand the use of anti-inflammatory agents in the treatment of extreme dry eye Understand the benefits and contraindications for treatment of dry eye with topical ciclosporin and lifitegrast Understand the benefits, indications and contraindications of amniotic membrane therapy for dry eye NOTE: Optomery Australia members can enter their details at the bottom of this article to have it automatically added to their Learning Plan.
Read More

Ikervis ciclosporin emulsion

Ikervis [ciclosporin 0.1% ophthalmic emulsion] is a ciclosporin emulsion for the treatment of severe keratitis in adults with dry eye disease that has not improved with artificial tears.1
Read More

Cationorm – a treatment for dry eye

Cationorm (cationic nanoemulsion) is a new preservative-free, hydrating and lubricating emulsion which protects the eye surface, reducing the discomfort and irritation of persistent dry eye caused by prolonged use of contact lenses, or environmental conditions.1
Read More
Azura Ophthalmics meibomian gland dysfunction

Ikervis ciclosporin eye drop now PBS-listed

Pharmaceutical firm Seqirus has announced that its new therapy Ikervis is now available via the Pharmaceutical Benefits Scheme (PBS), making it Australia’s first listed disease modifying ciclosporin eye drop for severe keratitis in adults with dry eye disease (DED). Read More